1. Home
  2. LUNG vs EGHT Comparison

LUNG vs EGHT Comparison

Compare LUNG & EGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • EGHT
  • Stock Information
  • Founded
  • LUNG 1995
  • EGHT 1987
  • Country
  • LUNG United States
  • EGHT United States
  • Employees
  • LUNG N/A
  • EGHT N/A
  • Industry
  • LUNG Industrial Specialties
  • EGHT EDP Services
  • Sector
  • LUNG Health Care
  • EGHT Technology
  • Exchange
  • LUNG Nasdaq
  • EGHT Nasdaq
  • Market Cap
  • LUNG 248.0M
  • EGHT 250.2M
  • IPO Year
  • LUNG 2020
  • EGHT 1997
  • Fundamental
  • Price
  • LUNG $6.67
  • EGHT $1.96
  • Analyst Decision
  • LUNG Strong Buy
  • EGHT Buy
  • Analyst Count
  • LUNG 7
  • EGHT 6
  • Target Price
  • LUNG $13.71
  • EGHT $2.83
  • AVG Volume (30 Days)
  • LUNG 213.2K
  • EGHT 852.2K
  • Earning Date
  • LUNG 10-28-2024
  • EGHT 10-30-2024
  • Dividend Yield
  • LUNG N/A
  • EGHT N/A
  • EPS Growth
  • LUNG N/A
  • EGHT N/A
  • EPS
  • LUNG N/A
  • EGHT N/A
  • Revenue
  • LUNG $76,583,000.00
  • EGHT $723,565,000.00
  • Revenue This Year
  • LUNG $22.73
  • EGHT $0.85
  • Revenue Next Year
  • LUNG $19.02
  • EGHT $2.15
  • P/E Ratio
  • LUNG N/A
  • EGHT N/A
  • Revenue Growth
  • LUNG 26.26
  • EGHT N/A
  • 52 Week Low
  • LUNG $5.46
  • EGHT $1.51
  • 52 Week High
  • LUNG $14.84
  • EGHT $3.92
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 37.51
  • EGHT 50.53
  • Support Level
  • LUNG $6.39
  • EGHT $1.78
  • Resistance Level
  • LUNG $7.47
  • EGHT $2.20
  • Average True Range (ATR)
  • LUNG 0.36
  • EGHT 0.11
  • MACD
  • LUNG -0.20
  • EGHT -0.00
  • Stochastic Oscillator
  • LUNG 12.93
  • EGHT 42.86

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About EGHT 8x8 Inc

8x8 Inc provides contact-center-as-a-service and unified-communications-as-a-service software applications to approximately 2.5 million users. The company's unified platform enables omnichannel communication to assist employees in communicating across voice, video, text, chat, and contact centers. The Company also generates revenue from sales of hardware and professional services, which are complementary to the delivery of its integrated technology platform.. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: